Published online:
14 January 2019
The Psychoactive Substances Act commenced in July 2013 and was amended in May 2014. The Act makes products containing psychoactive substances, which are proven to have no more than a low risk of harm, available through a regulated market.
The purpose of this Act is to regulate the availability of psychoactive substances in New Zealand to protect the health of, and minimise harm to, individuals who use psychoactive substances.
This review has considered the effectiveness of the Act against its stated purpose.